No Data
No Data
French Health Agency Suspends Use of Valneva's Chikungunya Jab for 65 Years Old and Above
Valneva Provides Update on ACIP Recommendation for Its Chikungunya Vaccine IXCHIQ Among U.S. Travelers
Kepler Capital Remains a Buy on Valneva (0OB3)
Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, Including a Presentation on Its Chikungunya Vaccine IXCHIQ
12 Analysts Assess Valneva: What You Need To Know
Analysts Offer Insights on Healthcare Companies: Valneva (VALN), Centene (CNC) and Soleno Therapeutics (SLNO)